Search

Author/Creator de Haan, Rosemarie

1. Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells. Issue 3 (September 2015)

Authors:
Verhagen, Caroline V.M.; de Haan, Rosemarie; Hageman, Floor; Oostendorp, Tim P.D.; Carli, Annalisa L.E.; O'Connor, Mark J.; Jonkers, Jos; Verheij, Marcel; van den Brekel, Michiel W.; Vens, Conchita
Journal:
Radiotherapy and oncology
Issue:
Volume 116:Issue 3(2015:Sep.)
Page Start:
358
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials. Issue 3 (March 2018)

Authors:
de Haan, Rosemarie; Pluim, Dick; van Triest, Baukelien; van den Heuvel, Michel; Peulen, Heike; van Berlo, Damien; George, Jay; Verheij, Marcel; Schellens, Jan H.M.; Vens, Conchita
Journal:
Radiotherapy and oncology
Issue:
Volume 126:Issue 3(2018)
Page Start:
443
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search